DISCLOSEDQuarterly
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,123,929 sh · $106.5M
Filed 30 Jun 2026SEC 13Fview source
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,123,929 sh · $106.5M
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,437,705 sh · $96.7M
Renaissance Technologies
Inhibrx Biosciences Inc · NASDAQ
50,183 sh · $3.4M
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,437,705 sh · $113.6M
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,787,705 sh · $60.2M
Viking Global Investors
Inhibrx Biosciences Inc · NASDAQ
1,787,705 sh · $25.5M
BlackRock
Inhibrx Biosciences Inc · NASDAQ
683,075 sh · $9.7M